FANCI and prostate carcinoma: Prostate cancer tumor cells harboring a heterozygous deletion of FANCI were selectively eradicated by chemotherapy, while those with intact FANCI resisted chemotherapy, suggesting that FANCI could be a possible therapeutic target to convert resistant cancer cells to an eradicable state.